107 related articles for article (PubMed ID: 10425356)
21. Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100.
Joshi GV; Kevadiya BD; Bajaj HC
Drug Dev Ind Pharm; 2010 Sep; 36(9):1046-53. PubMed ID: 20545505
[TBL] [Abstract][Full Text] [Related]
22. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.
Otsuka M; Kato F; Matsuda Y; Ozaki Y
AAPS PharmSciTech; 2003; 4(2):E19. PubMed ID: 12916901
[TBL] [Abstract][Full Text] [Related]
23. Ranitidine tablets: an improved dissolution method.
Eyjolfsson R
Pharmazie; 2003 Mar; 58(3):220. PubMed ID: 12685820
[No Abstract] [Full Text] [Related]
24. Simultaneous non-destructive determination of two components of combined paracetamol and amantadine hydrochloride in tablets and powder by NIR spectroscopy and artificial neural networks.
Dou Y; Sun Y; Ren Y; Ju P; Ren Y
J Pharm Biomed Anal; 2005 Mar; 37(3):543-9. PubMed ID: 15740915
[TBL] [Abstract][Full Text] [Related]
25. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
26. Determination of binary polymorphic mixtures of fluconazole using near infrared spectroscopy and X-ray powder diffraction: a comparative study based on the pre-validation stage results.
Ziémons E; Bourichi H; Mantanus J; Rozet E; Lebrun P; Essassi E; Cherrah Y; Bouklouze A; Hubert P
J Pharm Biomed Anal; 2011 Jul; 55(5):1208-12. PubMed ID: 21466938
[TBL] [Abstract][Full Text] [Related]
27. [Comparative evaluation of the anionic superdisintegrant incorporation mode on the quality of ranitidine tablets].
Postolache L; Gafiţanu E
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):336-40. PubMed ID: 23077918
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous quantitative analysis of mebendazole polymorphs A-C in powder mixtures by DRIFTS spectroscopy and ANN modeling.
Kachrimanis K; Rontogianni M; Malamataris S
J Pharm Biomed Anal; 2010 Feb; 51(3):512-20. PubMed ID: 19833468
[TBL] [Abstract][Full Text] [Related]
29. Cross-allergy to ranitidine and nizatidine.
Morisset M; Moneret-Vautrin DA; Loppinet V; Grandidier S
Allergy; 2000 Jul; 55(7):682-3. PubMed ID: 10921476
[No Abstract] [Full Text] [Related]
30. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
31. An accurate quantitative analysis of polymorphic content by chemometric X-ray powder diffraction.
Suda M; Takayama K; Otsuka M
Anal Sci; 2008 Apr; 24(4):451-7. PubMed ID: 18403834
[TBL] [Abstract][Full Text] [Related]
32. Quantitative mineral phase analysis of dry powders using energy-dispersive X-ray diffraction.
O'Dwyer JN; Tickner JR
Appl Radiat Isot; 2008 Oct; 66(10):1359-62. PubMed ID: 18502649
[TBL] [Abstract][Full Text] [Related]
33. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
34. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.
Chieng N; Rades T; Saville D
Eur J Pharm Biopharm; 2008 Mar; 68(3):771-80. PubMed ID: 17945474
[TBL] [Abstract][Full Text] [Related]
35. Spectrophotometric determination of three anti-ulcer drugs through charge-transfer complexation.
Al-Ghannam S; Belal F
J AOAC Int; 2002; 85(5):1003-8. PubMed ID: 12374395
[TBL] [Abstract][Full Text] [Related]
36. An environmentally friendly reflectometric method for ranitidine determination in pharmaceuticals and human urine.
Lima LS; Weinert PL; Lemos SC; Sequinel R; Pezza HR; Pezza L
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1999-2004. PubMed ID: 18783980
[TBL] [Abstract][Full Text] [Related]
37. Artificial neural networks applied to the analysis of synchrotron nuclear resonant scattering data.
Planckaert N; Demeulemeester J; Laenens B; Smeets D; Meersschaut J; L'abbé C; Temst K; Vantomme A
J Synchrotron Radiat; 2010 Jan; 17(1):86-92. PubMed ID: 20029116
[TBL] [Abstract][Full Text] [Related]
38. Artificial neural networks for infant mortality modelling.
Gismondi RC; Almeida RM; Infantosi AF
Comput Methods Programs Biomed; 2002 Nov; 69(3):237-47. PubMed ID: 12204451
[TBL] [Abstract][Full Text] [Related]
39. Validation of four different spectrophotometric methods for simultaneous determination of Domperidone and Ranitidine in bulk and pharmaceutical formulation.
Abdel-Ghany MF; Abdel-Aziz O; Mohammed YY
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():30-40. PubMed ID: 25942082
[TBL] [Abstract][Full Text] [Related]
40. Application of vibrational spectroscopy, thermal analyses and X-ray diffraction in the rapid evaluation of the stability in solid-state of ranitidine, famotidine and cimetidine.
Jamrógiewicz M; Ciesielski A
J Pharm Biomed Anal; 2015 Mar; 107():236-43. PubMed ID: 25625474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
